Fen Xia
Impact in
- Oncology top 2%
- Cancer-related Molecular Pathways
- PARP inhibition in cancer therapy
- Cancer Research top 2%
- Carcinogens and Genotoxicity Assessment
Papers in
-
- DNA Repair Mechanisms 36
- CRISPR and Genetic Engineering 8
- Cancer therapeutics and mechanisms 6
- Oncology 24
- PARP inhibition in cancer therapy 10
- Cancer-related Molecular Pathways 8
- Co-authors
- Wil L. Santivasi (4 shared papers)Henning Willers (7 shared papers)Simon N. Powell (8 shared papers)Wensheng Zhang (4 shared papers)Tie‐Yan Liu (2 shared papers)Howard L. Liber (6 shared papers)Hang Li (2 shared papers)Azad Bonni (1 shared paper)
- Journals
- Cancer Research (6 papers)Journal of Biological Chemistry (4 papers)Scientific Reports (3 papers)Molecular and Cellular Biology (3 papers)PLoS ONE (2 papers)
- Partner nations
- United StatesChinaSwitzerland
In The Last Decade
Fen Xia
91 papers receiving 4.9k citations
Fen Xia's Hit Papers
Peers
Comparison fields: 5 of 168
- Oncology 1.3k
- Cancer Research 659
- Molecular Biology 2.9k
- Genetics 529
- Developmental Neuroscience 63
Countries citing papers authored by Fen Xia
This map shows the geographic impact of Fen Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fen Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fen Xia more than expected).
Fields of papers citing papers by Fen Xia
This network shows the impact of papers produced by Fen Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fen Xia. The network helps show where Fen Xia may publish in the future.
Co-authors
The 25 scholars most cited alongside Fen Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 95 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 437 | |
| 2 | Listwise approach to learning to rank Hit paper breakdown → | 2008 | 434 |
| 3 | 2013 | 418 | |
| 4 | 2010 | 291 | |
| 5 | 2003 | 255 | |
| 6 | 2001 | 201 | |
| 7 | Altered p53 status correlates with differences in sensitivity to radiation-induced mutation and apoptosis in two closely related human lymphoblast lines. | 1995 | 183 |
| 8 | 2013 | 177 | |
| 9 | 1998 | 171 | |
| 10 | 2007 | 140 | |
| 11 | 2010 | 107 | |
| 12 | Nonhomologous end-joining of ionizing radiation-induced DNA double-stranded breaks in human tumor cells deficient in BRCA1 or BRCA2. | 2001 | 103 |
| 13 | 2008 | 102 | |
| 14 | 2021 | 93 | |
| 15 | 2006 | 87 | |
| 16 | 1993 | 85 | |
| 17 | 2000 | 83 | |
| 18 | 1994 | 77 | |
| 19 | 2020 | 64 | |
| 20 | 2018 | 63 |
About Fen Xia
Fen Xia is a scholar working on Molecular Biology, Oncology, Artificial Intelligence, Genetics and Information Systems, having authored 95 papers that have together received 4.9k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (36 papers), BRCA gene mutations in cancer (10 papers), PARP inhibition in cancer therapy (10 papers), Cancer-related Molecular Pathways (8 papers), CRISPR and Genetic Engineering (8 papers), Cancer therapeutics and mechanisms (6 papers), Machine Learning and Data Classification (5 papers) and Text and Document Classification Technologies (5 papers). The work is most often cited by research in Oncology (1.3k citations), Cancer Research (659 citations), Molecular Biology (2.9k citations), Genetics (529 citations) and Developmental Neuroscience (63 citations). Fen Xia has collaborated with scholars based in United States, China and Switzerland. Frequent co-authors include Wil L. Santivasi, Henning Willers, Simon N. Powell, Wensheng Zhang, Tie‐Yan Liu, Howard L. Liber, Hang Li, Azad Bonni, Jue Wang and Michael E. Greenberg. Their work appears in journals such as Cancer Research, Journal of Biological Chemistry, Scientific Reports, Molecular and Cellular Biology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.